Kliininen tutkimuskeskus
Clinical Research Center

Julkaisut 2009
Publications 2009

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Alafuzoff I et al. Beta-amyloid deposition in brains of subjects with diabetes.
2 Ederle J et al. Long-term outcome of endovascular treatment versus medical care for carotid artery stenosis in patients not suitable for surgery and randomised in the Carotid and Vertebral Artery Transluminal Angioplasty study (CAVATAS).
3 Eskelinen MH et al. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study.
4 Feldman HH et al. Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease.
5 Ferris S et al. Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.
6 Helisalmi S et al. Flanking markers of cyntation C (CST3) gene do not show association with Alzheimer's disease.
7 Hicks AU et al. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery.
8 Hiltunen M et al. Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus.
9 Håkansson K et al. Association between mid-life marital status and cognitive function in later life: population based cohort study.
10 Jauhiainen AM et al. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
11 Julkunen V et al. Cortical thickness analysis to detect progressive mild cognitive impairment: a reference to Alzheimer's disease.
12 Korolainen MA, Pirttilä T. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.
13 Kurl S et al. Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men.
14 Kurl S et al. Exercise workload, cardiovascular risk factor evaluation and the risk of stroke in middle-aged men.
15 Kärkkäinen M et al. Physical tests for patient selection for bone mineral density measurements in postmenopausal women.
16 Laakso MP et al. Olfactory identification in non-demented elderly population and mild cognitive impairment: a comparison of performance in clinical odor identification versus Boston Naming Test.
17 Lambert JC et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.
18 Liapis CD et al. ESVS guidelines. Invasite treatment for carotid stenosis: indications, techniques.
19 Lovestone S et al. AddNeuroMed - The European collaboration for the discovery of novel biomarkers for Alzheimer's disease.
20 Lu A et al. Effects of ubiquillin 1 on the unfolded protein response.
21 Luukkainen-Markkula R et al. Rehabilitation of hemispatial neglect: A randomized study using either arm activation or visual scanning training.
22 Mattsson N et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
23 Miettinen SSA et al. Effect of locally administered zoledronic acid on injury-induced intramembranous bone regeneration and osseointegration of a titanium implant in rats.
24 Nordberg A et al. Different cholinesterase inhibitor effects on CSF cholines Alzheimer patients.
25 Ojala J et al. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients.
26 Palmio J et al. Cerebrospinal fluid tau as a marker of neuronal damage after epileptic seizure.
27 Pentti K et al. Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study.
28 Peskind E et al. Safety of lumbar puncture procedures in patients with Alzheimer's disease.
29 Peurala SH et al. Effects of intensive therapy using gait trainer or floor walking exercise early after stroke.
30 Pihlajamäki M et al. Structural and functional MRI in mild cognitive impairment.
31 Quinn TJ et al. Evidence-based stroke r-ehabilitation: an expanded guidance document from the european stroke organisation (ESO) guidelines for management of ischaemic stroke and transient ischaemic attack 2008.
32 Remes A et al. Alzheimerin taudin merkkitekijöiden käyttö muistisairauksien diagnostiikassa.
33 Salovaara K et al. Nilkkamurtumien vaaratekijät - OSTPRE-murtumakohortin väestöpohjainen riskitekijäanalyysi 13,9 vuoden seurannassa.
34 Sarajärvi T et al. Down-regulation of seladin-1 increases BACE1 levels and activity through enhanced GGA3 depletion during apoptosis.
35 Simmons A et al. MRI measures of Alzheimer's disease and the AddNeuroMed study.
36 Singer D et al. Immuno-PCR-based quantification of multiple phosphorylated tau-epitopes linked to Alzheimer's disease.
37 Sirola J et al. Sister's fracture history may be associated with perimenopausal bone fragility and modifies the predictability of fracture risk.
38 Sivenius J et al. Modelling the burden of stroke in Finland until 2030.
39 Soininen H. Muistihäiriöpotilaan neurologisten löydösten diagnostiset vihjeet.
40 Solomon A et al. Serum total cholesterol, statins and cognition in non-demented elderly.
41 Solomon A et al. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
42 Tapiola T et al. Cerebrospinal fluid {beta}-amyloid 42 and Tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
43 van de Pol LA et al. White matter hyperintensities and medial temporal lobe atrophy in clincal subtypes of mild cognitive impairment: the DESCRIPA study.
44 Vepsäläinen S et al. Combined risk effects of IDE and NEP gene variants on Alzheimer disease.
45 Verwey NA et al. A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease.
46 Visser PJ et al. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
47 Viswanathan J et al. An association study between granulin gene polymorphisms and Alzheimer's disease in Finnish population.
48 Välimäki TH et al. Caregiver depression is associated with a low sense of coherence and health-related quality of life.
49 Wallin A, Pirttilä T. Biomarkers in vascular dementia.

Kliininen tutkimuskeskus Clinical Research Center
Julkaisutietokanta 27.5.2010 Publications Data Base 27.5.2010